- Home
- OUSTZ vs WGSWW Comparison
OUSTZ vs WGSWW Comparison
Compare OUSTZ & WGSWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OUSTZ
- WGSWW
- Stock Information
- Founded
- OUSTZ N/A
- WGSWW 2017
- Country
- OUSTZ United States
- WGSWW United States
- Employees
- OUSTZ 192
- WGSWW 1000
- Industry
- OUSTZ Industrial Machinery/Components
- WGSWW Retail: Computer Software & Peripheral Equipment
- Sector
- OUSTZ Industrials
- WGSWW Technology
- Exchange
- OUSTZ Nasdaq
- WGSWW Nasdaq
- Market Cap
- OUSTZ N/A
- WGSWW N/A
- IPO Year
- OUSTZ N/A
- WGSWW N/A
- Fundamental
- Price
- OUSTZ $0.08
- WGSWW $0.10
- Analyst Decision
- OUSTZ
- WGSWW
- Analyst Count
- OUSTZ 0
- WGSWW 0
- Target Price
- OUSTZ N/A
- WGSWW N/A
- AVG Volume (30 Days)
- OUSTZ N/A
- WGSWW 36.6K
- Earning Date
- OUSTZ N/A
- WGSWW 02-18-2025
- Dividend Yield
- OUSTZ N/A
- WGSWW N/A
- EPS Growth
- OUSTZ N/A
- WGSWW N/A
- EPS
- OUSTZ N/A
- WGSWW N/A
- Revenue
- OUSTZ N/A
- WGSWW $305,450,000.00
- Revenue This Year
- OUSTZ N/A
- WGSWW N/A
- Revenue Next Year
- OUSTZ N/A
- WGSWW N/A
- P/E Ratio
- OUSTZ N/A
- WGSWW N/A
- Revenue Growth
- OUSTZ N/A
- WGSWW 50.79
- 52 Week Low
- OUSTZ N/A
- WGSWW $0.17
- 52 Week High
- OUSTZ N/A
- WGSWW $0.21
- Technical
- Relative Strength Index (RSI)
- OUSTZ N/A
- WGSWW N/A
- Support Level
- OUSTZ N/A
- WGSWW N/A
- Resistance Level
- OUSTZ N/A
- WGSWW N/A
- Average True Range (ATR)
- OUSTZ 0.00
- WGSWW 0.00
- MACD
- OUSTZ 0.00
- WGSWW 0.00
- Stochastic Oscillator
- OUSTZ 0.00
- WGSWW 0.00
About OUSTZ Ouster Inc. Warrants
Ouster Inc is a provider of lidar sensors for the automotive, industrial, robotics, and smart infrastructure industries. Ouster's products include high-resolution scanning and solid-state digital lidar sensors, Velodyne Lidar sensors, and software solutions. The company operates in the Americas, Asia and Pacific, Europe, Middle East, and Africa regions. It derives maximum revenue from Americas.
About WGSWW GeneDx Holdings Corp.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.